VAM
ALBO

Visium Asset Management’s Albireo Pharma Inc ALBO Stock Holding History

Visium Asset Management’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-6,323
Closed -$436K – 1064
2013
Q4 		$436K Buy
+6,323
New +$463K 0.01% 607

Other funds holding ALBO

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
FNYS
First New York Securities New York $53.7M AUM 57.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Visium Asset Management's ALBO Position: Q1 2014 in Review

Visium Asset Management sold out of Albireo Pharma Inc (ALBO) in Q1 2014, closing a stake of 6,323 shares — an estimated $436K sold.

Visium Asset Management first reported a position in ALBO in Q4 2013 and held it in 1 quarter. The position peaked at $436K in Q4 2013. 43 funds tracked by Wall St. Rank hold ALBO as of Q1 2014.

  • Visium Asset Management reported no remaining Albireo Pharma Inc position as of Q1 2014 after selling out during the quarter.
  • Visium Asset Management sold 6,323 Albireo Pharma Inc shares in Q1 2014, an estimated $436K.
  • Visium Asset Management first reported a position in Albireo Pharma Inc in Q4 2013 and held it in 1 quarter.
  • Visium Asset Management's Albireo Pharma Inc position peaked at $436K in Q4 2013.
  • 43 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2014.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.